Search

everythinglearnresearchcommunity

for

Search:↓

A genetic marker linked to a type of hair loss was found in most patients studied.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

Certain RNAs may help diagnose alopecia areata by affecting keratin genes.

Researchers found two new genetic variants linked to Alzheimer's disease.

IMA and IMA/albumin levels don't predict alopecia areata severity.

Not having the gene PLAAT3 leads to fat loss, high insulin resistance, and abnormal fat levels in the blood due to a disruption in fat cell development and function.

Higher levels of MIG and IP-10 may help diagnose and monitor Alopecia Areata.

Your genes, especially IL-1a, can predict how well a hair growth treatment with platelet rich plasma will work for you.

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.

Mutations in the RBPJ gene cause Adams-Oliver Syndrome.

Activated platelet-rich plasma is a safe and effective treatment for hair loss.

AP collagen peptides may help hair grow better and become stronger.

Higher IL-37 levels are linked to more severe alopecia areata, but the gene variation doesn't affect disease risk.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with less inflammation.

Targeting MIG and MCP-1 may help treat inflammation in alopecia areata.

A protein called ectodysplasin-A2 increases a hair growth inhibitor in balding cells, which could be a target for hair loss treatment.

Epigenetic changes in blood cells may contribute to alopecia areata.

Loss of Rap1 protein speeds up heart aging in mice.

PPAR-γ may be a key target for treating alopecia areata and other skin conditions.

Women with hair loss may have higher heart disease risk.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

The ABCA4 gene protects hair follicle stem cells from toxic vitamin A byproducts.

Finasteride reduces AML cell growth by inhibiting androgen receptors.

Higher miR-34a levels and the A variant of the MIR-34A gene are linked to increased risk and severity of alopecia areata.

VLDL could be an early warning sign for male pattern baldness.

Higher IL-17A levels indicate more severe alopecia areata.

CD44 variant changes start alopecia areata, but don't maintain it.

hsa-miR-193a-5p may help diagnose and treat alopecia areata.

ABO/Rh blood groups are not a risk factor for PCOS.

Higher PD-1 levels mean fewer CD8+ T cells in alopecia areata hair follicles.